Literature DB >> 22287577

VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution.

Revu Ann Alexander1, Gerald W Prager, Judit Mihaly-Bison, Pavel Uhrin, Stefan Sunzenauer, Bernd R Binder, Gerhard J Schütz, Michael Freissmuth, Johannes M Breuss.   

Abstract

AIMS: Vascular endothelial growth factor (VEGF)-initiated angiogenesis requires coordinated proteolytic degradation of extracellular matrix provided by the urokinase plasminogen activator/urokinase receptor (uPA/uPAR) system and regulation of cell migration provided by integrin-matrix interaction. In this study, we investigated the mechanisms underlying the uPAR-dependent modulation of VEGF-induced endothelial migration. METHODS AND
RESULTS: We used flow cytometry to quantify integrins at the cell surface. Stimulation of human and murine endothelial cells with VEGF resulted in internalization of α5β1-integrins. Micropatterning and immunocytochemistry revealed co-clustering of uPAR and α5β1-integrins and retrieval via clathrin-coated vesicles. It was also contingent on receptors of the low-density lipoprotein receptor (LDL-R) family. VEGF-induced integrin redistribution was inhibited by elimination of uPAR from the endothelial cell surface or by inhibitory peptides that block the uPAR-integrin interaction. Under these conditions, the migratory response of endothelial cells upon VEGF stimulation was impaired both in vitro and in vivo.
CONCLUSIONS: The observations indicate that uPAR is an essential component of the network through which VEGF controls endothelial cell migration. uPAR is a bottleneck through which the VEGF-induced signal must be funnelled for both focused proteolytic activity at the leading edge and for redistribution of integrins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287577      PMCID: PMC6176909          DOI: 10.1093/cvr/cvs017

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  24 in total

1.  Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.

Authors:  R P Czekay; T A Kuemmel; R A Orlando; M G Farquhar
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

2.  Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells.

Authors:  Ying Wei; Chi-Hui Tang; Young Kim; Liliane Robillard; Feng Zhang; Matthias C Kugler; Harold A Chapman
Journal:  J Biol Chem       Date:  2006-12-04       Impact factor: 5.157

3.  Identification of the urokinase receptor as an adhesion receptor for vitronectin.

Authors:  Y Wei; D A Waltz; N Rao; R J Drummond; S Rosenberg; H A Chapman
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

4.  Proceedings: Tumor angiogenesis factor.

Authors:  J Folkman
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

5.  An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.

Authors:  Roberta Mazzieri; Silvia D'Alessio; Richard Kamgang Kenmoe; Liliana Ossowski; Francesco Blasi
Journal:  Mol Biol Cell       Date:  2005-11-02       Impact factor: 4.138

6.  Density enhanced phosphatase-1 down-regulates urokinase receptor surface expression in confluent endothelial cells.

Authors:  Patrick M Brunner; Patricia C Heier; Judit Mihaly-Bison; Ute Priglinger; Bernd R Binder; Gerald W Prager
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

7.  A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth.

Authors:  Pratima Chaurasia; Julio A Aguirre-Ghiso; Olin D Liang; Henrik Gardsvoll; Michael Ploug; Liliana Ossowski
Journal:  J Biol Chem       Date:  2006-03-17       Impact factor: 5.157

8.  Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells.

Authors:  Gerald W Prager; Johannes M Breuss; Stefan Steurer; Judit Mihaly; Bernd R Binder
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

9.  Beta1 integrin expression on endothelial cells is required for angiogenesis but not for vasculogenesis.

Authors:  Harikrishna Tanjore; Elisabeth M Zeisberg; Behzad Gerami-Naini; Raghu Kalluri
Journal:  Dev Dyn       Date:  2008-01       Impact factor: 3.780

10.  Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes.

Authors:  J Bohuslav; V Horejsí; C Hansmann; J Stöckl; U H Weidle; O Majdic; I Bartke; W Knapp; H Stockinger
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more
  30 in total

1.  Endothelial responses of magnesium and other alloying elements in magnesium-based stent materials.

Authors:  Nan Zhao; Donghui Zhu
Journal:  Metallomics       Date:  2014-11-03       Impact factor: 4.526

Review 2.  Role of the AP-1 transcription factor FOSL1 in endothelial cells adhesion and migration.

Authors:  Federico Galvagni; Maurizio Orlandini; Salvatore Oliviero
Journal:  Cell Adh Migr       Date:  2013-07-25       Impact factor: 3.405

Review 3.  Regulation of VEGF signaling by membrane traffic.

Authors:  Arie Horowitz; Himabindu Reddy Seerapu
Journal:  Cell Signal       Date:  2012-05-19       Impact factor: 4.315

4.  Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.

Authors:  Victoria Stepanova; Padma-Sheela Jayaraman; Sergei V Zaitsev; Tatiana Lebedeva; Khalil Bdeir; Rachael Kershaw; Kelci R Holman; Yelena V Parfyonova; Ekaterina V Semina; Irina B Beloglazova; Vsevolod A Tkachuk; Douglas B Cines
Journal:  J Biol Chem       Date:  2016-05-04       Impact factor: 5.157

5.  The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responses.

Authors:  Nurit P Azouz; Mario A Ynga-Durand; Julie M Caldwell; Ayushi Jain; Mark Rochman; Demetria M Fischesser; Leanne M Ray; Mary C Bedard; Melissa K Mingler; Carmy Forney; Matthew Eilerman; Jonathan T Kuhl; Hua He; Jocelyn M Biagini Myers; Vincent A Mukkada; Philip E Putnam; Gurjit K Khurana Hershey; Leah C Kottyan; Ting Wen; Lisa J Martin; Marc E Rothenberg
Journal:  Sci Transl Med       Date:  2018-06-06       Impact factor: 17.956

Review 6.  Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities.

Authors:  Anna Laurenzana; Gabriella Fibbi; Anastasia Chillà; Giancarlo Margheri; Tommaso Del Rosso; Elisabetta Rovida; Mario Del Rosso; Francesca Margheri
Journal:  Cell Mol Life Sci       Date:  2015-01-01       Impact factor: 9.261

7.  Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.

Authors:  Jianbo Wu; Tammy L Strawn; Mao Luo; Liqun Wang; Rong Li; Meiping Ren; Jiyi Xia; Zhuo Zhang; Weizhong Ma; Tingting Luo; Daniel A Lawrence; William P Fay
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-06       Impact factor: 8.311

8.  Epithelial ovarian cancer-induced angiogenic phenotype of human omental microvascular endothelial cells may occur independently of VEGF signaling.

Authors:  Boleslaw K Winiarski; Katarzyna I Wolanska; Srijana Rai; Tahanver Ahmed; Nigel Acheson; Nicholas J Gutowski; Jacqueline L Whatmore
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

Review 9.  VEGF-initiated angiogenesis and the uPA/uPAR system.

Authors:  Johannes M Breuss; Pavel Uhrin
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

10.  Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.

Authors:  Gretchen A Larusch; Alona Merkulova; Fakhri Mahdi; Zia Shariat-Madar; Robert G Sitrin; Douglas B Cines; Alvin H Schmaier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.